In light of the Food and Drug Administration's February 27, 2021 emergency use authorization for Janssen's COVID-19 vaccine, the Cystic Fibrosis Foundation reaffirms our support of the U.S. Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices' (ACIP) recommendations regarding the use of COVID-19 vaccines produced by Pfizer-BioNTech, Moderna, and Janssen. We continue to strongly encourage people with cystic fibrosis to talk with their CF care team about getting vaccinated.

Like all Americans, people with CF need a vaccine distribution strategy that is both aggressive and predictable. States should follow the guidelines issued by the ACIP and ensure that all people at high risk are able to access vaccines as soon as possible. 

The Foundation continues to closely monitor the implementation of vaccine allocation throughout the country and advocate that people with CF should be prioritized to receive the vaccine. We also recognize that the rollout of the vaccines has been confusing and complicated. To help navigate the system and ease the process for getting vaccinated, we recommend people with CF and their families follow these tips: 

• Be prepared. Gather your personal details, like medical insurance information and documentation that indicates your CF diagnosis before getting started.  
• Don't limit yourself to only one place.  Check for available appointments from several trusted sources, like your local health department, hospitals, or pharmacies that are giving vaccinations. 
• Sign up for alerts. Some state and local governments, hospitals, and pharmacies have websites where you can enter an email or phone number to have them notify you when appointments become available. 

You can read more about our vaccine advocacy efforts here and detailed vaccines related Q&As here.